NASDAQ:CORT | Jotup

Thinking about trading options or stock in Exxon Mobil, Amazon.com, Meta Platforms, Enterprise Products Partners, or Corcept Therapeutics?

Retrieved on:

Tuesday, January 2, 2024

NEW YORK, Jan. 2, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for XOM, AMZN, META, EPD, and CORT.

Key Points:

NEW YORK, Jan. 2, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for XOM, AMZN, META, EPD, and CORT.
Click a link below then choose between in-depth options trade idea report or a stock score report.
Options Report – Ideal trade ideas on up to seven different options trading strategies.
The report shows all vital aspects of each option trade idea for each stock.

Corcept Therapeutics Inc. Investors: Company Investigated by the Portnoy Law Firm

Retrieved on:

Thursday, December 29, 2022

CORT, Record, Therapy, Corcept Therapeutics, Sale

LOS ANGELES, Dec. 29, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Corcept Therapeutics Inc. (“Corcept” or the “Company”) (NASDAQ: CORT) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.

Key Points:

LOS ANGELES, Dec. 29, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Corcept Therapeutics Inc. (“Corcept” or the “Company”) (NASDAQ: CORT) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.
Investors are encouraged to contact attorney Lesley F. Portnoy , by phone 310-692-8883 or email : [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com .
The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing.

EQUITY ALERT: Rosen Law Firm Encourages Corcept Therapeutics Incorporated Investors to Inquire About Class Action Investigation – CORT

Retrieved on:

Wednesday, December 28, 2022

Class Action Lawsuit, Professional Services, Legal, Titan, CORT, Corcept Therapeutics, Advertising, I-Space (Chinese company), Security (finance)

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Corcept Therapeutics Incorporated (NASDAQ: CORT).

Key Points:

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Corcept Therapeutics Incorporated (NASDAQ: CORT).
The Rosen Law firm is preparing a class action seeking recovery of investor losses.
The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Corcept Therapeutics Incorporated and Encourages Investors with Losses to Contact the Firm

Retrieved on:

Friday, December 16, 2022

Class Action Lawsuit, Professional Services, Legal, Light, Certification, CORT, Ethics, Suite, Corcept Therapeutics, Security (finance)

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Corcept Therapeutics Incorporated (Corcept or the Company) (NASDAQ: CORT ) for violations of the securities laws.

Key Points:

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Corcept Therapeutics Incorporated (Corcept or the Company) (NASDAQ: CORT ) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Corcept Therapeutics Incorporated and Encourages Investors with Losses to Contact the Firm

Retrieved on:

Thursday, December 15, 2022

Class Action Lawsuit, Professional Services, Legal, Light, Certification, CORT, Ethics, Suite, Corcept Therapeutics, Security (finance)

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Corcept Therapeutics Incorporated (Corcept or the Company) (NASDAQ: CORT ) for violations of the securities laws.

Key Points:

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Corcept Therapeutics Incorporated (Corcept or the Company) (NASDAQ: CORT ) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

Bragar Eagel & Squire, P.C. Is Investigating Corcept, Discover, Mercury, and Fulgent and Encourages Investors to Contact the Firm

Retrieved on:

Saturday, September 17, 2022

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points:

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
On this news, Corcepts stock price fell $3.71 per share, or 16.91%, to close at $18.23 per share on December 8, 2021.
For more information on the Fulgent investigation go to: https://bespc.com/cases/FLGT
About Bragar Eagel & Squire, P.C.
The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Bragar Eagel & Squire, P.C. Is Investigating Medallion, RBB, Agrify, and Corcept and Encourages Investors to Contact the Firm

Retrieved on:

Monday, September 12, 2022

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points:

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
On this news, Medallions stock fell up to 27% during intraday trading on December 29, 2021, thereby injuring investors.
For more information on the Corcept investigation go to: https://bespc.com/cases/CORT
About Bragar Eagel & Squire, P.C.
The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Bragar Eagel & Squire, P.C. Is Investigating Medallion, RBB, Agrify, and Corcept and Encourages Investors to Contact the Firm

Retrieved on:

Wednesday, September 7, 2022

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points:

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
On this news, Medallions stock fell up to 27% during intraday trading on December 29, 2021, thereby injuring investors.
For more information on the Corcept investigation go to: https://bespc.com/cases/CORT
About Bragar Eagel & Squire, P.C.
The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Bragar Eagel & Squire, P.C. Is Investigating Medallion, RBB, Agrify, and Corcept and Encourages Investors to Contact the Firm

Retrieved on:

Thursday, September 1, 2022

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points:

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
On this news, Medallions stock fell up to 27% during intraday trading on December 29, 2021, thereby injuring investors.
For more information on the Corcept investigation go to: https://bespc.com/cases/CORT
About Bragar Eagel & Squire, P.C.
The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Bragar Eagel & Squire, P.C. Is Investigating Medallion, RBB, Agrify, and Corcept and Encourages Investors to Contact the Firm

Retrieved on:

Saturday, August 27, 2022

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points:

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
On this news, Medallions stock fell up to 27% during intraday trading on December 29, 2021, thereby injuring investors.
For more information on the Corcept investigation go to: https://bespc.com/cases/CORT
About Bragar Eagel & Squire, P.C.
The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.